Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 02, 2022	Jan. 03, 2021	Dec. 29, 2019
Cash flows from operating activities:
Net income	$ 200,392	$ 117,832	$ 136,940
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	125,540	132,775	131,693
Share-based compensation	22,019	18,930	18,676
Impairment of long-lived assets	2,251	8,037	6,999
Deferred income tax	(13,781)	10,266	837
Non-cash rental expense, net	40,596	28,937	28,202
Change in operating lease liabilities	(45,606)	(40,905)	(41,911)
Net receipt (recognition) of deferred vendor incentives	715	2,495	(501)
System optimization gains, net	(33,545)	(3,148)	(1,283)
Gain on sale of investments, net	(63)	0	(24,496)
Distributions received from TimWen joint venture	16,337	8,376	13,400
Equity in earnings in joint ventures, net	(11,203)	(6,096)	(8,673)
Long-term debt-related activities, net (see below)	24,758	6,723	15,317
Other, net	(13,242)	(6,438)	(4,838)
Changes in operating assets and liabilities:
Accounts and notes receivable, net	(5,613)	(16,243)	16,935
Inventories	(872)	(841)	(163)
Prepaid expenses and other current assets	(3,396)	(8,780)	(1,569)
Advertising funds restricted assets and liabilities	11,519	49,052	(2,720)
Accounts payable	7,586	1,620	1,054
Accrued expenses and other current liabilities	21,380	(18,231)	5,034
Net cash provided by operating activities	345,772	284,361	288,933
Cash flows from investing activities:
Capital expenditures	(77,984)	(68,969)	(74,453)
Acquisitions	(123,069)	(4,879)	(5,052)
Dispositions	55,118	6,091	3,448
Proceeds from sale of investments	63	169	24,496
Notes receivable, net	1,203	(662)	(3,370)
Payments for investments	(10,000)	0	0
Net cash used in investing activities	(154,669)	(68,250)	(54,931)
Cash flows from financing activities:
Proceeds from long-term debt	1,100,000	153,315	850,000
Repayments of long-term debt	(970,344)	(191,462)	(899,800)
Repayments of finance lease liabilities	(13,640)	(8,383)	(6,835)
Deferred financing costs	(20,873)	(2,122)	(14,008)
Repurchases of common stock, including accelerated share repurchase	(268,531)	(62,173)	(217,797)
Dividends	(94,846)	(64,866)	(96,364)
Proceeds from stock option exercises	30,003	23,361	28,328
Payments related to tax withholding for share-based compensation	(4,511)	(5,577)	(8,820)
Net cash used in financing activities	(242,742)	(157,907)	(365,296)
Net cash (used in) provided by operations before effect of exchange rate changes on cash	(51,639)	58,204	(131,294)
Effect of exchange rate changes on cash	364	1,330	3,489
Net (decrease) increase in cash, cash equivalents and restricted cash	(51,275)	59,534	(127,805)
Cash, cash equivalents and restricted cash at beginning of period	418,241	358,707	486,512
Cash, cash equivalents and restricted cash at end of period	366,966	418,241	358,707
Long-term debt-related activities, net:
Loss on early extinguishment of debt	17,917	0	8,496
Accretion of long-term debt	1,177	1,161	1,272
Amortization of deferred financing costs	5,664	5,562	5,549
Long-term debt-related activities, net:	24,758	6,723	15,317
Cash paid for:
Interest	133,284	136,228	138,270
Income taxes, net of refunds	54,779	16,202	34,798
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	6,158	3,673	6,026
Finance leases	82,032	34,918	50,061
Reconciliation of cash, cash equivalents and restricted cash at end of period:
Cash and cash equivalents	249,438	306,989	300,195
Restricted cash	27,535	33,973	34,539
Restricted cash, included in Advertising funds restricted assets	89,993	77,279	23,973
Total cash, cash equivalents and restricted cash	$ 366,966	$ 418,241	$ 358,707